• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Patricia Horgas, MSN

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Natalie Mortensen, MSN, RN, NI-BC

Latest:

Scaling Care Coordination Through Digital Engagement: Stepped-Wedge Trial Assessing Readmissions

This evaluation looks at a postdischarge digital engagement (PDDE) program using causal inference methods to examine the impact of PDDE on readmission.


Karen Kelly-Blake, PhD

Latest:

Type 2 Diabetes Patient Activation and mHealth Interventions Decreased Cardiovascular Disease Risk

Mobile health (mHealth) and a patient activation program could serve as a model for improving health outcomes for patients in outpatient clinical settings by decreasing atherosclerotic cardiovascular disease risk score.


Eric Johnson, PhD

Latest:

Advanced Care at Home at Scale in an Integrated Health Care System

Advanced care at home (otherwise known as hospital at home) can be scaled and provide care for a sizable portion of a hospital’s inpatient census, creating hospital capacity in an integrated delivery system.


M. Thomas Bateman Jr, PharmD, BCACP

Latest:

Pharmacist-Led Review of Empagliflozin and Ertugliflozin Following Formulary Update

Management of empagliflozin and ertugliflozin may be suboptimal following an insurance carrier’s formulary updates. Pharmacists may improve the management.


Jessica Marzulli, MA

Latest:

High-Intensity Home-Based Rehabilitation in a Medicare Accountable Care Organization

High-intensity home-based rehabilitation (HIHR) may substitute for facility-based postacute rehabilitation. Patients in HIHR had better functional outcomes at lower costs than patients in facility-based care.


Sara B. McMenamin, PhD, MPH

Latest:

Responsibility for Treating Tobacco Dependence in Health Clinics Serving Medicaid Enrollees

This article describes the implementation of Medicaid smoking cessation guidance in a large, urban federally qualified health center to examine how state-level provisions translated into clinic-level policies.


Guy Young, MD

Latest:

How Fitusiran Changes the Treatment Landscape in Hemophilia: Guy Young, MD

ATLAS trial investigator Guy Young, MD, Children's Hospital Los Angeles and University of Southern California Keck School of Medicine, highlights the current treatment options for patients with hemophilia A or B, with or without inhibitors, since the FDA approval of fitusiran (Qfitlia; Sanofi).


Luc Overholt, MD

Latest:

Patient and Supporter Factors Affecting Engagement With Diabetes Telehealth

Family support with medication management and recent urgent self-management concerns are 2 novel factors, among others, that predict completion of diabetes telehealth calls.


Susan Dentzer, MS

Latest:

Health Outcomes Under Full-Risk Medicare Advantage vs Traditional Medicare

Physician groups under 2-sided risk–based Medicare Advantage provide care associated with higher quality and efficiency compared with care by these same groups under fee-for-service Medicare.


Julie P. W. Bynum, MD, MPH

Latest:

Accountable Care Organizations and Use of Surgery Among Patients With Alzheimer Disease and Related Dementias

The decision to pursue surgery in patients with Alzheimer disease and related dementias is challenging. Accountable care organizations may influence decisions to pursue surgery in this population.


Ashley A. Dyer, MPH

Latest:

Guideline-Informed Care Among Medicaid-Enrolled Children With Food Allergy

This article describes food allergy–related service utilization and identifies factors associated with guideline-informed care among Medicaid-enrolled US children with food allergy.


Mahmoud Abdel-Rasoul, MS, MPH

Latest:

The Biosimilar Shift: Trending Infliximab Biosimilar Utilization and Associated Cost Savings for Commercial Insurance

Infliximab biosimilars created price competition causing insurance claims costs for infliximab originator and infliximab biosimilars to decrease, generating significant savings to the health care system.


Chau N. Truong, PhD

Latest:

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.


Jaja Okigwe

Latest:

Contributor: Providers and Employers Need to Collaborate More to Avoid a Greater Crisis

It can be hard to think about the bigger picture while in the middle of a crisis, but providers and employers should use this opportunity to work together on new and alternative models of care delivery and financing that directly affect cost, outcomes, and experience.


Jessica Y. Lee, DDS, PhD, MPH

Latest:

Pricing and Insurance Networks in Outpatient Surgery Markets

This article examines how prices, insurer payments, and patient payments for outpatient surgeries differ by site of care and network status.


Enbal Shacham, PhD

Latest:

Integrating Mental Health Care Services Into HIV Comprehensive Care

Distinguishing between need and receipt of integrated services reveals that mental health care improves the likelihood of medication adherence among people living with HIV.


Kelly E. Anderson, PhD, MPP

Latest:

Medicare Advantage Coverage Restrictions for the Costliest Physician-Administered Drugs

Four large Medicare Advantage insurers manage access to expensive physician-administered drugs with a combination of prior authorization, step therapy, and Part D formulary design.


Matthew Lucci, MPH

Latest:

Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

We examine the incidence and impact of chemotherapy induced peripheral neuropathy on clinical and economic outcomes in women with metastatic breast cancer initiating intravenous paclitaxel/nab-paclitaxel.


Julie Rodman, OD, MS, FAAO

Latest:

Multimodal Imaging Can Be Used to Manage AMD

Multimodal imaging is a useful tool in diagnosing and managing age-related macular degeneration (AMD), according to Julie Rodman, OD, MS, FAAO.


Madison Noble, MPH

Latest:

Modeling the Economic Value of Cardiometabolic Virtual-First Care Programs

Using a microsimulation approach, this study modeled the potential multiyear health and economic benefits of participating in cardiometabolic virtual-first care programs.



Shelley Duggan, MD

Latest:

Impact of Payment Models on Medical Specialist Physician Practice Patterns

This article explores the impact of payment models (fee for service vs salary based) on practice patterns, including wait times and care for patients with chronic diseases.


Aozhou Wu, PhD

Latest:

Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes

This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.


Jessica R. Castle, MD

Latest:

Combined Effect of Continuous Glucose Monitoring and Semaglutide: Analysis of Administrative Claims

Claims data reveal larger hemoglobin A1c decreases in people with type 2 diabetes who use continuous glucose monitoring and semaglutide compared with semaglutide alone.


Alanna M. Chamberlain, PhD

Latest:

Patient-Centered Communication and Outcomes in Heart Failure

Among community patients living with heart failure, excellent and good patient-centered communication was associated with a reduced risk of death.


Erin Weber, MS

Latest:

AI’s Future in Health Care Depends on Data Standardization, Collaboration: Erin Weber, MS

Erin Weber, MS, CAQH, is hopeful that artificial intelligence (AI) will empower people rather than replace them.


Karin M. Nelson, MD, MSHS

Latest:

Changes in Electronic Notification Volume and Primary Care Provider Burnout

Primary care provider burnout was analyzed before and after a national initiative to optimize the electronic health record inbox notification system at the Veterans Health Administration.


Christof Vulsteke, MD, PhD

Latest:

KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials: Christof Vulsteke, MD, PhD

Perioperative enfortumab vedotin plus pembrolizumab demonstrated significant results in a population that represents roughly half of all patients with MIBC, explained Christof Vulsteke, MD, PhD.


Dr Vivek Subbiah | Image Credit: TargetCancer Foundation
Vivek Subbiah, MD

Latest:

ESMO Congress Marks 50 Years by Showcasing the Future of Cancer Care: Vivek Subbiah, MD

Vivek Subbiah, MD, highlights key topics at the 50th European Society for Medical Oncology (ESMO) Congress, including the rise of tumor-agnostic therapies and the use of artificial intelligence (AI) in cancer care.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.